The Efficacy of Tocilizumab in the Treatment of Patients with Refractory Immune-Mediated Necrotizing Myopathies: An Open-Label Pilot Study

Objective: To evaluate the efficacy of tocilizumab (TCZ) in adult patients with refractory immune-mediated necrotizing myopathies (IMNMs) and investigate possible predictive biomarkers of the response to treatment with TCZ. Methods: Patients with refractory IMNM were enrolled in this open-label pilo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Sizhao, Li, Wenli, Jiang, Wei, He, Linrong, Peng, Qinglin, Wang, Guochun, Lu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010666/
https://www.ncbi.nlm.nih.gov/pubmed/33815117
http://dx.doi.org/10.3389/fphar.2021.635654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010666/
https://www.ncbi.nlm.nih.gov/pubmed/33815117
http://dx.doi.org/10.3389/fphar.2021.635654

Ejemplares similares